The United States devotes more money to health care than any other high income country, yet high spending alone does not settle the question of value. The central issue is not simply that Americans use medical services, but that a fragmented financing system, high underlying prices, market structure, and growing demand combine to make care unusually costly for households, employers, and public budgets.
A Spending Gap That Remains Wide
U.S. national health expenditure reached $5.3 trillion in 2024, equal to $15,474 per person and 18 percent of gross domestic product, according to the Centers for Medicare and Medicaid Services. This was a 7.2 percent increase from 2023, following growth of 7.4 percent in the previous year.
International comparisons underline the scale of the gap. The OECD estimates that the United States spent about $14,885 per person in 2024, adjusted for purchasing power, compared with an OECD average of $5,967. American spending was therefore roughly two and a half times the average across peer economies.
These totals do not mean that every patient faces identical costs, since insurance, employer contributions, government programs, and out of pocket payments distribute the burden differently. Nevertheless, national expenditure ultimately affects wages, taxes, insurance premiums, deductibles, and the financial choices patients make when they need treatment.
High Prices Shape the System
A major explanation is the price paid for care. OECD analysis finds that the United States is among the countries with the highest health sector prices, with a comparable basket of health care goods and services costing 52 percent more than the OECD average.
Hospitals illustrate the significance of this issue. Hospital care accounted for nearly one third of U.S. health spending in 2024. Between 2022 and 2024, hospital spending rose by $277 billion, representing 40 percent of the overall growth in national health expenditures during that period. Physician and clinical services also constituted a large share of spending, reaching about $1.1 trillion in 2024.
Prices can be influenced by local bargaining conditions. Research summarized by the Medicare Payment Advisory Commission indicates that hospital mergers generally lead to higher inpatient prices, while physician and hospital integration can raise prices for physician services paid by both commercial insurers and Medicare. Consolidation does not automatically produce higher costs in every setting, and some organizations argue it can improve coordination or preserve access. However, when fewer providers operate in a market, insurers and patients may have fewer alternatives, weakening pressure to contain prices.
Complexity Carries its Own Cost
The American system also relies on numerous private plans, employer arrangements, and public programs, each with different benefit rules, provider networks, payment rates, and billing requirements. This structure can offer choice and permit tailored coverage, but it also requires extensive claims processing, contracting, coding, authorization procedures, and compliance work.
Administrative complexity matters because it raises the operating cost of delivering care before a clinician provides treatment. These expenses may be passed through in premiums and negotiated payment rates. At the same time, administrative processes can serve legitimate functions, including fraud prevention, quality reporting, and management of limited resources. The policy challenge is therefore to distinguish necessary oversight from duplication that imposes costs without improving care or patient experience.
Demand and Medical Need are Rising
Recent spending growth cannot be attributed to prices alone. CMS reported that greater use and intensity of services were important drivers in 2023 and 2024, particularly for hospital care, physician services, and prescription drugs. This reflects several overlapping pressures, including an aging population, chronic illness, postponed care during the earlier stages of the pandemic, and broader availability of advanced treatments.
Greater use of care is not inherently undesirable. It may signal improved access, earlier diagnosis, or effective treatment for conditions that were previously unmanaged. Yet a system that pays largely per service can create strong incentives to expand the volume and complexity of billable care. This makes prevention, coordinated primary care, and evaluation of clinical value important parts of any cost discussion.
A Final Note
America’s health care costs arise from interconnected forces rather than a single cause. Higher prices, administrative fragmentation, provider market concentration, and increased demand all contribute. The practical implication is that durable cost restraint is likely to require several approaches at once, while protecting access, quality, medical innovation, and financial security for patients.
